pSivida Corp (PSDV)

1.22
0.03 2.40
NASDAQ : Health Care
Prev Close 1.25
Open 1.22
Day Low/High 1.15 / 1.27
52 Wk Low/High 2.37 / 5.81
Volume 728.05K
Avg Volume 394.00K
Exchange NASDAQ
Shares Outstanding 39.37M
Market Cap 49.22M
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

First Week of January 2018 Options Trading For pSivida (PSDV)

Investors in pSivida Corp saw new options begin trading this week, for the January 2018 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 238 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

PSivida Announces 13 New Patents Issued Or Allowed

PSivida Announces 13 New Patents Issued Or Allowed

U.S. and foreign patents for bioerodible Medidur™, new smaller needle Medidur injector and Tethadur™

Primary Endpoint Met In PSivida's Utilization Study Of New Medidur™ Inserter With Smaller Diameter Needle

Primary Endpoint Met In PSivida's Utilization Study Of New Medidur™ Inserter With Smaller Diameter Needle

Results to Form Part of Planned Applications for Marketing Approvals in EU and US

TheStreet Quant Rating: D- (Sell)